MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.carrev.2021.12.024

Медицинская библиотека · Cardiovascular revascularization medicine : including molecular interventions · 2021

One-Year Outcomes for Patients Undergoing Transcatheter Aortic Valve Replacement: The Gulf TAVR Registry.

Alasnag Mirvat, AlMerri Khaled, Almoghairi Abdulrahman, Alenezi Abdullah, Bardooli Fawaz, Al-Sheikh Shereen, Alanazi Nouf, AlHarbi Waleed, Al Lawati Hatim, Al Faraidy Khalid, AlShehri Mohammed, Thabane Michael, Thabane Lehana, Al-Shaibi Khaled

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

The use of transcatheter aortic valve replacement (TAVR) is steadily increasing with TAVR procedures offered to patients across the entire spectrum of surgical risks. The Gulf TAVR registry captures the demographics of patients undergoing TAVR in the Gulf region, comorbidities that drive outcomes, procedural success, complications, and one-year outcomes of death or rehospitalization.

METHODS

This is a retrospective cohort study for adult patients aged at least 18 years undergoing TAVR at eight centers in the Gulf region. The primary outcome was a composite of death or re-hospitalization at one-year. Secondary outcomes included the individual components of the composite, stroke, and myocardial infarction (MI). We used multivariable Cox regression to determine factors associated with the composite endpoint.

RESULTS

A total of 795 patients (56% male) were included in the final analysis with a mean age of 74.6 (standard deviation (SD) 8.9) years, Society of Thoracic Surgeons Score (STS) Score 4.9 (4.2), ejection fraction of 53% (12.7%). Transfemoral approach was employed in over 95% (762/795). The primary outcomes rate was 12.8% (95% confidence interval [CI]: 10.6-15.4); secondary endpoints were death 5.4% (95% CI 4.0-7.2); stroke 0.8% (95% CI 0.3, 1.7), MI 0.8% (95% CI 0.4-1.9), rehospitalization: 9.3% (95% CI 7.5-11.5) of whom 71.6% were related to cardiovascular causes. 77% of the cardiovascular admissions were attributable to heart failure or the need for pacemaker implantation. Stage IV or V chronic kidney disease was significantly associated with the primary composite endpoint (Hazard Ratio: 2.49, [95% CI: 1.31, 4.73], p = 0.005). Although not significant, paravalvular leak and severe left ventricular dysfunction showed a 2-fold and 3-fold increased risk for the composite endpoint, respectively.

CONCLUSIONS

The Gulf TAVR registry is the first of its kind in the region. It profiles an elderly population with a high procedural success rate and a low rate of complications. One-year outcomes were primarily driven by repeat hospitalization for heart failure and pacemaker implantation indicating a need to optimize heart failure management and improve algorithms for the detection of conduction abnormalities.

Для цитирования: Alasnag Mirvat, AlMerri Khaled, Almoghairi Abdulrahman, Alenezi Abdullah, Bardooli Fawaz, Al-Sheikh Shereen, Alanazi Nouf, AlHarbi Waleed, Al Lawati Hatim, Al Faraidy Khalid, AlShehri Mohammed, Thabane Michael, Thabane Lehana, Al-Shaibi Khaled. One-Year Outcomes for Patients Undergoing Transcatheter Aortic Valve Replacement: The Gulf TAVR Registry.. Cardiovascular revascularization medicine : including molecular interventions. 2021. DOI: 10.1016/j.carrev.2021.12.024.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.